UBS Group AG - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 32 filers reported holding SCPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$103,468
-39.2%
14,532
-13.0%
0.00%
Q2 2023$170,142
+668.0%
16,697
+440.4%
0.00%
Q4 2022$22,155
+121.6%
3,090
+43.6%
0.00%
Q2 2022$10,000
+66.7%
2,152
+115.2%
0.00%
Q1 2022$6,000
-45.5%
1,000
-55.6%
0.00%
Q4 2021$11,000
+83.3%
2,253
+167.3%
0.00%
Q3 2021$6,000
+50.0%
843
+19.7%
0.00%
Q2 2021$4,000
-75.0%
704
-70.5%
0.00%
Q1 2021$16,000
+77.8%
2,384
+38.4%
0.00%
Q4 2020$9,000
+80.0%
1,723
+135.7%
0.00%
Q3 2020$5,000
-61.5%
731
-58.1%
0.00%
Q2 2020$13,000
+333.3%
1,745
+410.2%
0.00%
Q1 2020$3,000
-70.0%
342
-80.8%
0.00%
Q4 2019$10,000
-23.1%
1,781
-57.7%
0.00%
Q2 2019$13,000
+62.5%
4,211
+58.3%
0.00%
Q1 2019$8,000
-90.2%
2,660
-87.8%
0.00%
Q4 2018$82,000
+645.5%
21,742
+1090.0%
0.00%
Q3 2018$11,000
+22.2%
1,827
+9.3%
0.00%
Q2 2018$9,000
-30.8%
1,671
+50.8%
0.00%
Q4 2017$13,0001,1080.00%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,831,474$20,268,0006.83%
AIGH Capital Management LLC 637,322$3,372,0001.37%
Worth Venture Partners, LLC 162,875$862,0000.68%
Ikarian Capital, LLC 1,466,147$7,756,0000.34%
RA Capital Management 3,518,998$18,615,0000.26%
Orbimed Advisors 4,797,148$25,377,0000.22%
DAFNA Capital Management LLC 38,891$206,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 150,699$797,0000.03%
Alyeska Investment Group, L.P. 355,690$1,882,0000.03%
ALGERT GLOBAL LLC 13,860$73,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders